BHST — BioHarvest Sciences Inc. Common Stock
$1.660.00%
Last close: · regular session
Last 60 sessions
BHST closed at $1.66 (0.00%) on Oct 30, 2026. Float: 14.5M shares. Latest SEC filing: 6-K on Oct 29, 2026.
Opening the full analysis uses 1 of your 3 free tickers today.
Chart, dilution, float and news for BHST in the TickerWise workspace.
BioHarvest Sciences Inc. operates as a biotechnology company. The company operates through Nutraceuticals and Pharmaceuticals segments. It develops botanical synthesis platform technology to grow the ingredients in any plant enzymes or cells. The company is leveraging its botanical synthesis technology to develop science-based and clinically proven therapeutic solutions in nutraceuticals and pharmaceuticals verticals. It also operates as a contract development and manufacturing operation services. In addition, the company offers wellness products. Further, it offers VINIA, a red grape cell dietary supplement containing the matrix of polyphenols contained in red grapes. The company operates in Israel and the United States. BioHarvest Sciences Inc. is based in Vancouver, Canada.
Company profile
- Sector: Basic Materials
- Industry: Agricultural Inputs
- Country: CA
- Exchange: NASDAQ
- Employees: 87
- Website: https://www.bioharvest.com
Latest SEC filings for BHST
Latest BHST news
- BioHarvest takes second plant-cell asset to commercial readiness Read article
- Tate & Lyle and Bioharvest Reach Key Milestone in Next-Generation Sweetener Development Programme Read article
Related companies
Opening the full analysis uses 1 of your 3 free tickers today.
Educational tool only — not investment advice.